IL6 and depressive symptom measurement: This process disrupts the activation of the IL-6/STAT3 signaling pathway, alleviating neuroinflammation by suppressing proinflammatory mediators, while enhancing synaptic plasticity ultimately ameliorates depression-like behaviors (Bai et al., 2023).